Head-to-head · free

Faeth Therapeutics, Inc. vs iRhythm Technologies, Inc.

FTH vs IRTC — return on capital, cash generation, margins and balance sheet side by side.

FTH

1 / 4

measures where FTH leads

IRTC

3 / 4

measures where IRTC leads

A simple count of which company scores better on each measure — not a recommendation to buy or sell.

MeasureFTH · FY2025IRTC · FY2025
Revenue—$747.1M
Net income(21.1M)(44.6M)
Revenue growth (yearly, multi-year)—23.3%
Free cash flow(20.5M)$34.5M
Free cash flow margin—4.6%
Net cash / (debt)——
ROIC——
Return on equity-74.0%-36.6%
Gross margin—70.6%
Operating margin—-6.7%
Net debt / EBITDA0.39x-13.37x

Figures are as reported by each company; latest fiscal year shown.

Where Faeth Therapeutics, Inc.'s cash went (FY2025)

Capital spending
$16000
Buybacks
—
Dividends
—
Acquisitions
—
Net debt issued / (repaid)
—
Full FTH profile →

Where iRhythm Technologies, Inc.'s cash went (FY2025)

Capital spending
$46.3M
Buybacks
—
Dividends
—
Acquisitions
—
Net debt issued / (repaid)
—
Full IRTC profile →

Ask which business is stronger

"Which one reinvests at higher returns?" "Who carries more risk in its filings?" Get answers drawn straight from both companies' filings.

Compare them free

More comparisons